Alpha Tau Medical is a clinical-stage medical technology company developing Alpha DaRT, a form of alpha-radiation brachytherapy for solid tumors. The approach implants radioactive sources that emit short-range alpha particles intended to damage cancer cells while limiting exposure to surrounding tissue. It targets oncology settings seeking localized radiotherapeutic options still under clinical development.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 0 | — | -10.1 | — |
| Q3 2025 | 0 | — | -11.7 | — |
| Q4 2025 | 0 | — | -12.1 | — |
| Q1 2026 | 0 | — | -22.9 | — |
| Q2 2026 | 0 | — | -45.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Winmark Corporation (WINA), Tandem Diabetes Care, Inc. (TNDM), Fluence Energy, Inc. (FLNC), IRADIMED CORPORATION (IRMD), Iambic Therapeutics, Inc. (IAM), Heritage Financial Corporation (HFWA)